1 Study Coverage
1.1 Gene Therapies for Cancer Treatment Revenue in Gene Therapies for Cancer Treatment Business (2017-2022) & (US$ Million) Introduction
1.2 Global Gene Therapies for Cancer Treatment Outlook 2017 VS 2022 VS 2028
1.2.1 Global Gene Therapies for Cancer Treatment Market Size for the Year 2017-2028
1.2.2 Global Gene Therapies for Cancer Treatment Market Size for the Year 2017-2028
1.3 Gene Therapies for Cancer Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Gene Therapies for Cancer Treatment in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Gene Therapies for Cancer Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Gene Therapies for Cancer Treatment Market Dynamics
1.4.1 Gene Therapies for Cancer Treatment Industry Trends
1.4.2 Gene Therapies for Cancer Treatment Market Drivers
1.4.3 Gene Therapies for Cancer Treatment Market Challenges
1.4.4 Gene Therapies for Cancer Treatment Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Gene Therapies for Cancer Treatment by Type
2.1 Gene Therapies for Cancer Treatment Market Segment by Type
2.1.1 Somatic Cell Gene Therapy (SCGT)
2.1.2 Germline Gene Therapy (GGT)
2.2 Global Gene Therapies for Cancer Treatment Market Size by Type (2017, 2022 & 2028)
2.3 Global Gene Therapies for Cancer Treatment Market Size by Type (2017-2028)
2.4 United States Gene Therapies for Cancer Treatment Market Size by Type (2017, 2022 & 2028)
2.5 United States Gene Therapies for Cancer Treatment Market Size by Type (2017-2028)
3 Gene Therapies for Cancer Treatment by Application
3.1 Gene Therapies for Cancer Treatment Market Segment by Application
3.1.1 Cancer Research Centers
3.1.2 Diagnostic Laboratories
3.1.3 Cancer Hospitals
3.1.4 Others
3.2 Global Gene Therapies for Cancer Treatment Market Size by Application (2017, 2022 & 2028)
3.3 Global Gene Therapies for Cancer Treatment Market Size by Application (2017-2028)
3.4 United States Gene Therapies for Cancer Treatment Market Size by Application (2017, 2022 & 2028)
3.5 United States Gene Therapies for Cancer Treatment Market Size by Application (2017-2028)
4 Global Gene Therapies for Cancer Treatment Competitor Landscape by Company
4.1 Global Gene Therapies for Cancer Treatment Market Size by Company
4.1.1 Top Global Gene Therapies for Cancer Treatment Companies Ranked by Revenue (2021)
4.1.2 Global Gene Therapies for Cancer Treatment Revenue by Player (2017-2022)
4.2 Global Gene Therapies for Cancer Treatment Concentration Ratio (CR)
4.2.1 Gene Therapies for Cancer Treatment Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Gene Therapies for Cancer Treatment in 2021
4.2.3 Global Gene Therapies for Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Gene Therapies for Cancer Treatment Headquarters, Revenue in Gene Therapies for Cancer Treatment Business (2017-2022) & (US$ Million) Type
4.3.1 Global Gene Therapies for Cancer Treatment Headquarters and Area Served
4.3.2 Global Gene Therapies for Cancer Treatment Companies Revenue in Gene Therapies for Cancer Treatment Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Gene Therapies for Cancer Treatment Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Gene Therapies for Cancer Treatment Market Size by Company
4.5.1 Top Gene Therapies for Cancer Treatment Players in United States, Ranked by Revenue (2021)
4.5.2 United States Gene Therapies for Cancer Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Gene Therapies for Cancer Treatment Market Size by Region
5.1 Global Gene Therapies for Cancer Treatment Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Gene Therapies for Cancer Treatment Market Size by Region (2017-2028)
5.2.1 Global Gene Therapies for Cancer Treatment Market Size by Region: 2017-2022
5.2.2 Global Gene Therapies for Cancer Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Gene Therapies for Cancer Treatment Market Size YoY Growth 2017-2028
6.1.2 North America Gene Therapies for Cancer Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Gene Therapies for Cancer Treatment Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Gene Therapies for Cancer Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Gene Therapies for Cancer Treatment Market Size YoY Growth 2017-2028
6.3.2 Europe Gene Therapies for Cancer Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Gene Therapies for Cancer Treatment Market Size YoY Growth 2017-2028
6.4.2 Latin America Gene Therapies for Cancer Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Gene Therapies for Cancer Treatment Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Gene Therapies for Cancer Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Takara Bio
7.1.1 Takara Bio Company Details
7.1.2 Takara Bio Business Overview
7.1.3 Takara Bio Gene Therapies for Cancer Treatment Introduction
7.1.4 Takara Bio Revenue in Gene Therapies for Cancer Treatment Business (2017-2022)
7.1.5 Takara Bio Recent Development
7.2 Tocagen
7.2.1 Tocagen Company Details
7.2.2 Tocagen Business Overview
7.2.3 Tocagen Gene Therapies for Cancer Treatment Introduction
7.2.4 Tocagen Revenue in Gene Therapies for Cancer Treatment Business (2017-2022)
7.2.5 Tocagen Recent Development
7.3 VBL Therapeutics
7.3.1 VBL Therapeutics Company Details
7.3.2 VBL Therapeutics Business Overview
7.3.3 VBL Therapeutics Gene Therapies for Cancer Treatment Introduction
7.3.4 VBL Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2017-2022)
7.3.5 VBL Therapeutics Recent Development
7.4 Cold Genesys
7.4.1 Cold Genesys Company Details
7.4.2 Cold Genesys Business Overview
7.4.3 Cold Genesys Gene Therapies for Cancer Treatment Introduction
7.4.4 Cold Genesys Revenue in Gene Therapies for Cancer Treatment Business (2017-2022)
7.4.5 Cold Genesys Recent Development
7.5 Genprex
7.5.1 Genprex Company Details
7.5.2 Genprex Business Overview
7.5.3 Genprex Gene Therapies for Cancer Treatment Introduction
7.5.4 Genprex Revenue in Gene Therapies for Cancer Treatment Business (2017-2022)
7.5.5 Genprex Recent Development
7.6 Momotaro-Gene
7.6.1 Momotaro-Gene Company Details
7.6.2 Momotaro-Gene Business Overview
7.6.3 Momotaro-Gene Gene Therapies for Cancer Treatment Introduction
7.6.4 Momotaro-Gene Revenue in Gene Therapies for Cancer Treatment Business (2017-2022)
7.6.5 Momotaro-Gene Recent Development
7.7 MultiVir
7.7.1 MultiVir Company Details
7.7.2 MultiVir Business Overview
7.7.3 MultiVir Gene Therapies for Cancer Treatment Introduction
7.7.4 MultiVir Revenue in Gene Therapies for Cancer Treatment Business (2017-2022)
7.7.5 MultiVir Recent Development
7.8 SynerGene Therapeutics
7.8.1 SynerGene Therapeutics Company Details
7.8.2 SynerGene Therapeutics Business Overview
7.8.3 SynerGene Therapeutics Gene Therapies for Cancer Treatment Introduction
7.8.4 SynerGene Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2017-2022)
7.8.5 SynerGene Therapeutics Recent Development
7.9 Ziopharm Oncology
7.9.1 Ziopharm Oncology Company Details
7.9.2 Ziopharm Oncology Business Overview
7.9.3 Ziopharm Oncology Gene Therapies for Cancer Treatment Introduction
7.9.4 Ziopharm Oncology Revenue in Gene Therapies for Cancer Treatment Business (2017-2022)
7.9.5 Ziopharm Oncology Recent Development
7.10 Anchiano Therapeutics
7.10.1 Anchiano Therapeutics Company Details
7.10.2 Anchiano Therapeutics Business Overview
7.10.3 Anchiano Therapeutics Gene Therapies for Cancer Treatment Introduction
7.10.4 Anchiano Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2017-2022)
7.10.5 Anchiano Therapeutics Recent Development
7.11 Celgene
7.11.1 Celgene Company Details
7.11.2 Celgene Business Overview
7.11.3 Celgene Gene Therapies for Cancer Treatment Introduction
7.11.4 Celgene Revenue in Gene Therapies for Cancer Treatment Business (2017-2022)
7.11.5 Celgene Recent Development
7.12 Celsion
7.12.1 Celsion Company Details
7.12.2 Celsion Business Overview
7.12.3 Celsion Gene Therapies for Cancer Treatment Introduction
7.12.4 Celsion Revenue in Gene Therapies for Cancer Treatment Business (2017-2022)
7.12.5 Celsion Recent Development
7.13 Bluebird Bio
7.13.1 Bluebird Bio Company Details
7.13.2 Bluebird Bio Business Overview
7.13.3 Bluebird Bio Gene Therapies for Cancer Treatment Introduction
7.13.4 Bluebird Bio Revenue in Gene Therapies for Cancer Treatment Business (2017-2022)
7.13.5 Bluebird Bio Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
